Cambridge Investment Research Advisors
TECH icon

Cambridge Investment Research Advisors’s Bio-Techne TECH Stock Holding History

Cambridge Investment Research Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$423K Buy
5,983
+764
+15% +$41.3K ﹤0.01% 3125
2026
Q1 		$273K Sell
5,219
-65
-1% -$3.9K ﹤0.01% 3380
2025
Q4 		$311K Buy
+5,284
New +$321K ﹤0.01% 3166
2025
Q1 		– Sell
-2,923
Closed -$211K – 3629
2024
Q4 		$211K Buy
2,923
+412
+16% +$30.3K ﹤0.01% 3159
2024
Q3 		$201K Sell
2,511
-395
-14% -$29.7K ﹤0.01% 3152
2024
Q2 		$208K Sell
2,906
-8,258
-74% -$608K ﹤0.01% 2998
2024
Q1 		$786K Sell
11,164
-237
-2% -$17K ﹤0.01% 1899
2023
Q4 		$880K Sell
11,401
-439
-4% -$28.9K ﹤0.01% 1731
2023
Q3 		$806K Sell
11,840
-849
-7% -$67.1K ﹤0.01% 1713
2023
Q2 		$1.04M Buy
12,689
+1,956
+18% +$157K ﹤0.01% 1586
2023
Q1 		$796K Sell
10,733
-1,024
-9% -$78.9K ﹤0.01% 1727
2022
Q4 		$974K Buy
11,757
+7,285
+163% +$579K 0.01% 1530
2022
Q3 		$318K Buy
4,472
+68
+2% +$5.88K ﹤0.01% 2315
2022
Q2 		$382K Sell
4,404
-7,060
-62% -$662K ﹤0.01% 2167
2022
Q1 		$1.24M Sell
11,464
-3,264
-22% -$337K 0.01% 1421
2021
Q4 		$1.91M Buy
14,728
+1,964
+15% +$241K 0.01% 1177
2021
Q3 		$1.55M Buy
12,764
+3,608
+39% +$439K 0.01% 1236
2021
Q2 		$1.03M Sell
9,156
-3,368
-27% -$355K ﹤0.01% 1513
2021
Q1 		$1.2M Buy
12,524
+124
+1% +$11.3K 0.01% 1309
2020
Q4 		$984K Buy
12,400
+3,228
+35% +$234K 0.01% 1312
2020
Q3 		$568K Sell
9,172
-93,556
-91% -$6.09M ﹤0.01% 1529
2020
Q2 		$6.78M Sell
102,728
-640
-0.6% -$38.3K 0.05% 341
2020
Q1 		$4.9M Buy
103,368
+9,028
+10% +$452K 0.05% 370
2019
Q4 		$5.18M Buy
94,340
+80,152
+565% +$4.21M 0.04% 457
2019
Q3 		$694K Buy
14,188
+12
+0.1% +$602 0.01% 1287
2019
Q2 		$739K Buy
14,176
+244
+2% +$12.3K 0.01% 1209
2019
Q1 		$692K Sell
13,932
-656
-4% -$29.5K 0.01% 1269
2018
Q4 		$528K Sell
14,588
-616
-4% -$25.7K 0.01% 1286
2018
Q3 		$776K Buy
15,204
+664
+5% +$29.4K 0.01% 1183
2018
Q2 		$538K Sell
14,540
-520
-3% -$19.9K 0.01% 1359
2018
Q1 		$569K Hold
15,060
– – 0.01% 1278
2017
Q4 		$488K Sell
15,060
-88
-0.6% -$2.8K 0.01% 1339
2017
Q3 		$458K Sell
15,148
-820
-5% -$24.3K 0.01% 1292
2017
Q2 		$469K Buy
15,968
+1,312
+9% +$35.9K 0.01% 1243
2017
Q1 		$372K Buy
14,656
+80
+0.5% +$2.06K 0.01% 1233
2016
Q4 		$375K Buy
14,576
+32
+0.2% +$841 0.01% 1161
2016
Q3 		$398K Sell
14,544
-84
-0.6% -$2.31K 0.01% 1156
2016
Q2 		$412K Buy
14,628
+532
+4% +$13.7K 0.01% 1027
2016
Q1 		$333K Buy
14,096
+36
+0.3% +$793 0.01% 1116
2015
Q4 		$316K Buy
14,060
+44
+0.3% +$1K 0.01% 1102
2015
Q3 		$324K Buy
+14,016
New +$351K 0.01% 990
2014
Q4 		– Sell
-15,376
Closed -$360K – 1481
2014
Q3 		$360K Buy
15,376
+404
+3% +$9.47K 0.01% 988
2014
Q2 		$346K Sell
14,972
-48
-0.3% -$1.06K 0.01% 945
2014
Q1 		$321K Hold
15,020
– – 0.01% 927
2013
Q4 		$355K Hold
15,020
– – 0.01% 803
2013
Q3 		$301K Sell
15,020
-1,948
-11% -$37K 0.01% 834
2013
Q2 		$293K Buy
+16,968
New +$282K 0.01% 769

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Cambridge Investment Research Advisors's TECH Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Bio-Techne (TECH) stake by 15% in Q2 2026, buying an estimated $41.3K and bringing the position to 5,983 shares worth $423K. The position accounts for ﹤0.01% of the portfolio, ranked #3125.

Cambridge Investment Research Advisors first reported a position in TECH in Q2 2013 and has held it in 47 quarters since. The position peaked at $6.78M in Q2 2020. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Cambridge Investment Research Advisors held 5,983 shares of Bio-Techne worth $423K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 764 Bio-Techne shares in Q2 2026, an estimated $41.3K.
  • Bio-Techne made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3125 holding.
  • Cambridge Investment Research Advisors first reported a position in Bio-Techne in Q2 2013 and has held it in 47 quarters since.
  • Cambridge Investment Research Advisors's Bio-Techne position peaked at $6.78M in Q2 2020.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.